Tubular aggregate myopathy (TAM) is a progressive disorder essentially involving muscle 23 weakness, cramps, and myalgia. TAM clinically overlaps with Stormorken syndrome 24 (STRMK), associating TAM with miosis, thrombocytopenia, hyposplenism, ichthyosis, short 25 stature, and dyslexia. TAM and Stormorken syndrome arise from gain-of-function mutations in 26 STIM1 or ORAI1, both encoding key regulators of Ca 2+ homeostasis, and mutations in either 27 gene results in excessive Ca 2+ entry. The pathomechanistic similarities and differences of TAM 28 and Stormorken syndrome are only partially understood. Here we provide functional in cellulo 29 experiments demonstrating that STIM1 harboring the TAM D84G or the STRMK R304W 30 mutation similarly cluster and exert a dominant effect on the wild-type protein. Both mutants 31 recruit ORAI1 to the clusters, induce major nuclear import of the Ca 2+ -dependent transcription 32 factor NFAT, and trigger the formation of circular membrane stacks. In conclusion, the 33 analyzed TAM and STRMK mutations have a comparable impact on STIM1 protein function 34 and downstream effects of excessive Ca 2+ entry, highlighting that TAM and Stormorken 35 syndrome involve a common pathomechanism. 36 37 Keywords: STIM1, tubular aggregate myopathy, Stormorken syndrome, SOCE, calcium 38 39 40 41 42 Functional analysis of STIM1 mutations 3 43 44 Tubular aggregate myopathy (TAM) and Stormorken syndrome (STRMK) are spectra of the 45 same disease affecting muscle, platelets, spleen, and skin (1, 2). The majority of the TAM 46 patients primarily present with muscle weakness, cramps, and myalgia with a heterogeneous 47 age of onset and disease severity (3-6). Additional features including thrombocytopenia, 48 hyposplenism, miosis, ichthyosis, short stature, hypocalcemia, or dyslexia can be seen as well, 49 and the occurrence of the totality of the multi-systemic signs constitutes the diagnosis of 50
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126
TAM and STRMK mutants constitutively cluster at the plasma membrane 127 We first assessed the effect of the TAM and STRMK-related STIM1 mutations on the SOCE-128 dependent accumulation of STIM1 in vicinity to the plasma membrane. To this aim, we 129 transfected C2C12 myoblasts with WT or mutant (TAM D84G or STRMK R304W) YFP-130 STIM1, and monitored the fluorescence by TIRF microscopy. Cells expressing WT STIM1 131 showed a diffuse signal inside the cell at the resting state, and addition of 2 µM thapsigargin 132 induced Ca 2+ -store depletion and the formation of STIM1 clusters at the plasma membrane 133 (Figure 1a ). This is in agreement with previous studies showing that STIM1 migrates to the microscopy on transfected C2C12 muscle cells demonstrates that wild type STIM1 has a diffuse 141 localization inside the cell, and clusters at the vicinity of the plasma membrane upon Ca 2+ store 142 depletion through thapsigargin (TG) . In contrast, both TAM D84G and STRMK R304W 143 mutants cluster without TG treatment and independently of the reticular Ca 2+ load. (b) Co-144 transfection of C2C12 cells with differentially tagged STIM1 constructs shows that D84G and 145 R304W STIM1 sequester wild type STIM1 to the clusters, revealing a dominant effect.
146
TAM and STRMK mutants sequester WT STIM1
147
Both TAM and Stormorken syndrome result from heterozygous STIM1 missense mutations (4, 148 10-12). To investigate a potential effect of mutant STIM1 on the wild type protein, we co-149 transfected C2C12 cells with WT or mutant YFP-STIM1 and WT mCherry-STIM1. Cells co-150 expressing differently tagged WT proteins displayed diffuse overlapping signals. Addition of 151 thapsigargin provoked co-clustering of both WT proteins, illustrating that the fluorescent YPF 152 and mCherry tags do not impact on the intracellular localization or clustering of STIM1 ( Figure   153 1b). Cells co-expressing D84G or R304W with WT STIM1 exhibited major STIM1 clusters of 154 overlapping YFP and mCherry signals without thapsigargin treatment. These results 155 demonstrate that both TAM and STRMK mutants recruit wild type STIM1 to the clusters 156 without Ca 2+ store depletion, and thereby evidence a dominant effect leading to the constitutive 157 clustering of WT STIM1.
158
TAM and STRMK mutants recruit ORAI1 and are less sensitive to Ca 2+ influx 159 The cytosolic coiled-coil domains of STIM1 contain the STIM1-ORAI1 activating domain 160 (SOAR), which is essential for the interaction with the plasma membrane Ca 2+ channel ORAI1 161 (26, 31, 32) . To examine the effect of the TAM and STRMK mutations on the recruitment of 162 ORAI1 to the STIM1 clusters, we transfected C2C12 cells with WT or mutant mCherry-STIM1 Functional analysis of STIM1 mutations 8 163 and WT ORAI1-eGFP ( Figure 2 ). When co-expressed, WT STIM1 and WT ORAI1 164 significantly co-cluster, and we also observed clusters containing STIM1 and ORAI1 in cells 165 expressing mutant D84G or R304W STIM1 and WT ORAI1. To investigate the influence of 166 Ca 2+ entry on the recruitment of ORAI1 to the STIM1 clusters, we next co-transfected HeLa 167 cells with WT or mutant mCherry-STIM and mutant V107M ORAI1-eGFP ( Figure 2 ). The
168
V107M mutation affects an essential amino acid of the pore-forming unit of ORAI1, and has 169 been shown to generate a channel with constant Ca 2+ permeability (15, 33) . Major clusters were 170 found in more than 80% of the cells expressing mutant STIM1 and mutant ORAI1, 171 demonstrating that the leaky V107M ORAI1 channel is largely recruited to the D84G or R304W 172 STIM1 clusters. In contrast, less than 10% of the cells expressing wild type STIM1 and mutant 173 ORAI1 displayed prominent clusters. These data illustrate that steady Ca 2+ inflow through 174 V107M ORAI1 efficiently disassembles or prevents the formation of wild type STIM1 clusters 175 and thereby inactivates SOCE, while the mutation-induced STIM1 clusters persist 176 independently of the Ca 2+ flux through the CRAC channel. In this study, we investigated the molecular impact of STIM1 mutations associated with tubular 237 aggregate myopathy (TAM) and Stormorken syndrome (STRMK) at different levels of the 238 SOCE pathway. We and others have previously shown that the TAM and STRMK mutations 239 induce constitutive STIM1 clustering and activation of the Ca 2+ entry channels (4, 10-12). Here 240 we addressed and compared the sequence of events leading to the cellular defects of TAM and 241 Stormorken syndrome, and we found that the TAM D84G and STRMK R304W mutants 242 similarly impact on STIM1 clustering, ORAI1 recruitment, Ca 2+ -dependent nuclear 243 translocation of NFAT, and the formation of circular membrane stacks.
244
The STIM1 mutations have multiple effects on cluster formation 245 Through TIRF experiments we showed that both TAM D84G and STRMK R304W STIM1 (1, 3) . The luminal R304W mutation does not interfere with Ca 2+ binding. Instead, a 251 recent study revealed that it induces a helical elongation within the coiled-coil domain, and 252 thereby promotes STIM1 clustering and the exposure of the SOAR domain (37). In both cases, 253 the mutations induce constitutive ORAI1 binding and activation, resulting in major 254 extracellular Ca 2+ influx despite replete Ca 2+ stores (4, 10-12).
255
In agreement with previous studies (26), we observed that exogenously expressed wild-type 256 STIM1 and ORAI1 co-localize and cluster in cells. However, co-expression of wild-type 257 STIM1 and V107M ORAI1, previously described to generate a leaky channel with reduced 258 Ca 2+ selectivity (15, 33), leads to a diffuse reticular distribution of STIM1. We therefore 259 conclude that the constant ion entry through the permeable ORAI1 V107M channel either Functional analysis of STIM1 mutations 12 260 dissipates the STIM1 clusters or prevents their formation. It is known that massive Ca 2+ entry 261 generates hyperpolarized potentials at the intracellular channel gate, and thereby promotes a 262 rapid inactivation of ORAI1 and the dissociation of STIM1 from ORAI1 (Ca 2+ -dependent 263 inactivation, CDI) (38, 39) . In contrast to wild-type STIM1, both TAM and STRMK mutants 264 efficiently recruited V107M ORAI1 to the clusters. This suggests that the interaction between 265 the STIM1 mutants and the leaky ORAI1 channel is insensitive to elevated local Ca 2+ levels, 266 and that the consequential reduction of CDI significantly contributes to excessive extracellular 267 Ca 2+ entry. Consistently, decreased CDI was measured in lymphoblasts from a Stormorken 268 syndrome patient, resulting in elevated basal Ca 2+ levels (12). 269 We furthermore found that the clusters in cells co-expressing wild-type and mutant STIM1 are 270 formed by both proteins despite replete Ca 2+ stores. This indicates that the TAM or STRMK 271 mutants are able to oligomerize with wild type STIM1 and to sequester the non-mutated protein 272 to the clusters. Such an effect has not yet been described for STIM1 mutations, and demonstrates 273 that wild-type STIM1 contributes to the constitutive activation of ORAI1 and the excessive 274 extracellular Ca 2+ entry characterizing TAM and Stormorken syndrome.
275
The downstream effects of excessive Ca 2+ entry 276 As a consequence of constitutive STIM1 and ORAI1 activation, myoblasts from TAM/STRMK 277 patients were found to exhibit increased basal Ca 2+ levels in the cytosol (4, 5, 7, 10-12). Ca 2+ is 278 a physiological key factor triggering numerous signalling cascades including the NFAT 279 pathway. The NFAT transcription factors mainly reside in the cytosol at low Ca 2+ 280 concentrations, and become phosphorylated upon rising Ca 2+ levels and translocate to the nuclei 281 (34). In agreement, we found that cells expressing mutant STIM1 and manifesting prominent 282 STIM1/ORAI1 clusters also displayed major nuclear NFAT translocation as compared to cells 283 expressing wild-type STIM1. This is consistent with previous reports showing that the (20, 42, 43) . Although it is not fully understood 290 how the tubular aggregates form, they were shown to contain sarcoplasmic reticulum proteins 291 and large amounts of Ca 2+ (19) , and are therefore likely to be the consequence of excessive Ca 2+ 292 storage in the reticulum. Accordingly, constitutive SOCE activation was shown to induce the 293 formation of membrane stacks in transfected cells (44), and our CLEM experiments on cells 294 expressing mutant STIM1 identified multilayer reticulum membranes of circular shape, which 295 may represent the first step of tubular aggregate formation. Of note, tubular aggregates were 296 not seen in the TAM/STRMK mouse model harbouring the STIM1 R304W mutation and 297 clinically recapitulating the human disorder (45), demonstrating that tubular aggregate 298 formation is species-specific and rather a consequence than a cause of the disease.
299
Common pathomechanisms in tubular aggregate myopathy and Stormorken syndrome 300 Tubular aggregate myopathy essentially affects skeletal muscle, and a subset of TAM patients 301 harboring STIM1 EF-hand mutations additionally manifested one or several signs of 302 Stormorken syndrome (3-5, 8, 9, 18 and Stormorken syndrome involve a common pathomechanism. The phenotypic differences 312 between both disorders might result from a different mutational impact on fast Ca 2+ -dependent 313 inactivation (CDI), corresponding to the inactivation of ORAI1 through high local Ca 2+ levels.
314
Indeed, electrophysiological studies have shown that the R304W mutant suppresses fast CDI, 315 while STIM1 harboring a luminal amino acid substitution was indistinguishable from the wild-316 type (12). This suggests that R304W, but not the EF-hand mutations causes a prolonged Ca 2+ 317 influx and might account for the significant aberrations in multiple tissues in patients with 318 Stormorken syndrome. Alternatively, especially the cytosolic STIM1 R304W mutation might 319 have an additional pathogenic effect on other interaction partners as the non-selective TRPC 320 channels (46), and the full clinical picture of Stormorken syndrome would then result from the 321 excessive entry of Ca 2+ and other cations in the different tissues.
322
Concluding remarks 323 Here we demonstrate that missense mutations in different STIM1 domains have a similar 324 pathogenic effect on SOCE and downstream pathways. Our finding that STIM1 mutations exert 325 a dominant effect points to a suitable therapeutic approach for TAM and Stormorken syndrome 326 through an allele-specific downregulation of STIM1 expression. The resulting reduction of the 327 STIM1 protein level is thereby not expected to be pathogenic as heterozygous carriers of STIM1 328 loss-of-function mutations, associated with immunodeficiency, are healthy(2). 
